Mount Sinai and Valley Health System to form partnership

MOUNT SINAI HEALTH SYSTEM and Valley Health System plan to form a partnership that will enable Valley to access Mount Sinai’s roster of clinical trials, as well as develop new programs and services.

In December 2015, Valley and Mount Sinai announced plans to collaborate on clinical programs, research and educational offerings. Mount Sinai and Valley plan to work together at Valley’s Blumenthal Cancer Center in Paramus and the main campus in Ridgewood by establishing a linked clinical information system.

According to Robert Korst, medical director of Valley’s Blumenthal Cancer Center, among the first Mount Sinai clinical trials that Valley patients will have access to include new treatments and treatment protocols for cutaneous malignancies, including melanoma and other skin cancers; genitourinary malignancies, including prostate and kidney cancers; and hematologic cancers and serious blood disorders, including leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes. Some treatment protocols will include bone marrow transplantation and immunotherapeutic vaccines.

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.

May 02, 2025

Vol.51 No.17

By Jacquelyn Cobb

Clinical

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

When Kelly Spill was eight months pregnant, she experienced some constipation and noticed blood in her stool. Her OBGYN wasn’t worried.

The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document

An updated version of President Trump’s budget request published on May 2 comes as a disappointment for those who hoped that the White House would rethink the draconian cuts contained in an earlier, confidential version of the document that ended up being leaked to the press.

May 02, 2025

Vol.51 No.17

By Jacquelyn Cobb and Claire Marie Porter

News Analysis

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

After nearly three decades of reviewing NCI-funded extramural projects and sometimes saving NCI from its own folly, the Board of Scientific Advisors has been terminated as part of the Trump administration’s drive to reduce the size of the federal government.

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

In the starkest opposition yet by Republicans to the Trump administration’s attacks on HHS agencies, senators from both parties sounded an alarm about the damage being done to biomedical research in the U.S.

May 02, 2025

Vol.51 No.17

By Claire Marie Porter

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

“We stand at the edge of discovery, and on the brink of losing it,” said Patricia M. LoRusso, the 2024-2025 president of the American Association for Cancer Research. “I believe this is the most scientifically promising moment in the history of cancer research.”

May 02, 2025

Vol.51 No.17

By Claire Marie Porter

Mount Sinai and Valley Health System to form partnership

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Renew today!

Subscriber content

Never miss an issue!

Login

Mount Sinai and Valley Health System to form partnership

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child

The White House “skinny budget” document cuts NIH by nearly 40%The cuts are consistent with the previously leaked “passback” document

NIH eliminates the NCI Board of Scientific AdvisorsOver its 28 year history, BSA shaped NCI-funded extramural science

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”Cancer research also took center stage at Senate appropriations hearing

Bertagnolli: NIH funding cuts are “unprecedented and harmful”AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”

Never miss an issue!

Login

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document

NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

Bertagnolli: NIH funding cuts are “unprecedented and harmful”
AACR panel challenges scientists to find stability in a period of “ventricular tachycardia”